Christopher Koh MD, MHSc

Christopher Koh was appointed NIDDK Clinical Director in December 2022. His research is both clinical and translational and is focused on liver disease. This includes assessing novel therapeutics, improving understanding of the pathogenesis of rare liver diseases, and characterizing liver disease in unique populations. Koh has been serving as the Acting Clinical Director since October 2020, managing high-quality clinical research and patient care in NIH’s Clinical Center.

Koh earned his Doctor of Medicine from Saba University School of Medicine in Saba, Dutch Caribbean, and holds a Master of Health Science from Duke University School of Medicine, Durham, North Carolina. After completing fellowships in gastroenterology and hepatology at the University of Maryland School of Medicine at Baltimore and NIDDK, Koh became an NIDDK staff clinician in the Liver Diseases Branch(external link) in 2013.

Among his many accomplishments, Koh has served in leadership roles in the NIDDK as Director of the Hepatology Fellowship Program and of the Gastroenterology Fellowship Program. He is the recipient of NCI and NIDDK Director's Awards and the NIDDK Nancy Nossal Scientific Mentorship Award; the author of more than 100 articles and book chapters; and a member of several editorial boards for gastrointestinal and hepatology journals. In addition to his Clinical Director duties, Koh continues to lead research on liver disease caused by chronic hepatitis D virus infection as a Senior Research Physician in NIDDK’s Liver Diseases Branch.